First Trust Capital Management’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

First Trust Capital Management’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-175,000	Closed	-$1.71M	–	432
2022 Q1	$1.71M	Hold	175,000	–	–	0.18%	103
2021 Q4	$1.73M	Hold	175,000	–	–	0.3%	88
2021 Q3	$1.73M	Hold	175,000	–	–	0.26%	94
2021 Q2	$1.76M	Buy	+175,000	New	+$1.76M	0.26%	84

Other funds holding ORIAU

JNE Partners London, United Kingdom $243M AUM 2.37% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

First Trust Capital Management's ORIAU Position: Q2 2022 in Review

First Trust Capital Management sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q2 2022, closing a stake of 175,000 shares — an estimated $1.71M sold.

First Trust Capital Management first reported a position in ORIAU in Q2 2021 and held it in 4 quarters. The position peaked at $1.76M in Q2 2021. 11 funds tracked by Wall St. Rank hold ORIAU as of Q2 2022.

First Trust Capital Management reported no remaining Orion Biotech Opportunities Corp. Units position as of Q2 2022 after selling out during the quarter.
First Trust Capital Management sold 175,000 Orion Biotech Opportunities Corp. Units shares in Q2 2022, an estimated $1.71M.
First Trust Capital Management first reported a position in Orion Biotech Opportunities Corp. Units in Q2 2021 and held it in 4 quarters.
First Trust Capital Management's Orion Biotech Opportunities Corp. Units position peaked at $1.76M in Q2 2021.
11 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q2 2022.

Based on First Trust Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.